company background image
BIOG B

BioGaia OM:BIOG B Stock Report

Last Price

kr99.05

Market Cap

kr10.0b

7D

6.9%

1Y

27.4%

Updated

26 Sep, 2023

Data

Company Financials +

BioGaia AB (publ)

OM:BIOG B Stock Report

Mkt Cap: kr10.0b

BIOG B Stock Overview

BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide.

BIOG B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Rewards

Price-To-Earnings ratio (24.1x) is below the Biotechs industry average (49.5x)
Earnings grew by 68.9% over the past year

Risk Analysis

High level of non-cash earnings
Dividend of 2.93% is not well covered by cash flows

BioGaia AB (publ) Competitors

Vitrolife

OM:VITR

kr19.1b

Probi

OM:PROB

kr2.2b

Swedish Orphan Biovitrum

OM:SOBI

kr74.9b

BioArctic

OM:BIOA B

kr24.5b

Price History & Performance

Summary of all time highs, changes and price drops for BioGaia
Historical stock prices
Current Share Pricekr99.05
52 Week Highkr119.40
52 Week Lowkr68.88
Beta0.71
1 Month Change-2.61%
3 Month Change-12.11%
1 Year Change27.40%
3 Year Change-12.03%
5 Year Change12.30%
Change since IPO1,153.80%

Recent News & Updates

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Sep 13
Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Recent updates

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Sep 13
Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Jun 02
Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 27
A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Jan 14
Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Aug 26
Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24
Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02
Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21
BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09
Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07
BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Apr 29
Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Mar 25
Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

Mar 04
The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Feb 11
CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 26
Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

Jan 11
What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Dec 27
How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Dec 13
Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain

Nov 28
BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain

Shareholder Returns

BIOG BSE BiotechsSE Market
7D6.9%0.2%-1.3%
1Y27.4%5.6%11.1%

Return vs Industry: BIOG B exceeded the Swedish Biotechs industry which returned 5.6% over the past year.

Return vs Market: BIOG B exceeded the Swedish Market which returned 11.1% over the past year.

Price Volatility

Is BIOG B's price volatile compared to industry and market?
BIOG B volatility
BIOG B Average Weekly Movement4.6%
Biotechs Industry Average Movement8.0%
Market Average Movement6.1%
10% most volatile stocks in SE Market11.8%
10% least volatile stocks in SE Market3.4%

Stable Share Price: BIOG B is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: BIOG B's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990215Isabelle Valerie Ducellierhttps://www.biogaia.com

BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula.

BioGaia AB (publ) Fundamentals Summary

How do BioGaia's earnings and revenue compare to its market cap?
BIOG B fundamental statistics
Market Capkr10.00b
Earnings (TTM)kr415.42m
Revenue (TTM)kr1.21b

24.1x

P/E Ratio

8.2x

P/S Ratio

Is BIOG B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
BIOG B income statement (TTM)
Revenuekr1.21b
Cost of Revenuekr330.33m
Gross Profitkr882.72m
Other Expenseskr467.30m
Earningskr415.42m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Oct 20, 2023

Earnings per share (EPS)4.11
Gross Margin72.77%
Net Profit Margin34.25%
Debt/Equity Ratio0%

How did BIOG B perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

35%

Payout Ratio